메뉴 건너뛰기




Volumn 31, Issue 6, 2008, Pages 753-760

Intravascular ultrasound assessment of coronary artery involvement in Fabry disease

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSPHINGOLIPID; LIPID;

EID: 57649176793     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-008-0794-0     Document Type: Article
Times cited : (18)

References (31)
  • 1
    • 42949119819 scopus 로고    scopus 로고
    • Elevated globotriaosylsphingosine is a hallmark of Fabry disease
    • Aerts JM, Groenr JE, Kuiper S, et al (2008) Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci U S A. 105: 2812-2817.
    • (2008) Proc Natl Acad Sci U S A. , vol.105 , pp. 2812-2817
    • Aerts, J.M.1    Groenr, J.E.2    Kuiper, S.3
  • 2
    • 0034943172 scopus 로고    scopus 로고
    • Enhanced endothelium-dependent vasodilatation in Fabry disease
    • Altarescu G, Moore DF, Pursley R, et al (2001) Enhanced endothelium-dependent vasodilatation in Fabry disease. Stroke 32: 1559-1562.
    • (2001) Stroke , vol.32 , pp. 1559-1562
    • Altarescu, G.1    Moore, D.F.2    Pursley, R.3
  • 3
    • 33646691525 scopus 로고    scopus 로고
    • Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease
    • doi: 10.1080/08035320600618924
    • Barbey F, Brakch N, Linhart A, et al (2006a) Increased carotid intima-media thickness in the absence of atherosclerotic plaques in an adult population with Fabry disease. Acta Paediatr Suppl 95: 63-68. doi: 10.1080/08035320600618924.
    • (2006) Acta Paediatr Suppl , vol.95 , pp. 63-68
    • Barbey, F.1    Brakch, N.2    Linhart, A.3
  • 4
    • 33646680506 scopus 로고    scopus 로고
    • Cardiac and vascular hypertrophy in Fabry disease. Evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition
    • doi: 10.1161/01.ATV.0000209649.60409.38
    • Barbey F, Brakch N, Linhart A, et al (2006b) Cardiac and vascular hypertrophy in Fabry disease. Evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26: 839-844. doi: 10.1161/01.ATV.0000209649.60409.38.
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 839-844
    • Barbey, F.1    Brakch, N.2    Linhart, A.3
  • 5
    • 0034852918 scopus 로고    scopus 로고
    • Non-invasive evaluation of arterial involvement in patients affected with Fabry disease
    • doi: 10.1136/jmg.38.9.629
    • Boutouyrie P, Laurent S, Laloux B, Lidove O, Grunfeld JP, Germain DP (2001) Non-invasive evaluation of arterial involvement in patients affected with Fabry disease. J Med Genet 38: 629-631. doi: 10.1136/ jmg.38.9.629.
    • (2001) J Med Genet , vol.38 , pp. 629-631
    • Boutouyrie, P.1    Laurent, S.2    Laloux, B.3    Lidove, O.4    Grunfeld, J.P.5    Germain, D.P.6
  • 6
    • 0018924075 scopus 로고
    • Stability of plasma low density lipoprotein with abnormal glycolipid composition from patients with Fabry's disease
    • doi: 10.1016/0021-9150(80)90081-7
    • Clarke JT, Stolz JM, Garner JB (1980) Stability of plasma low density lipoprotein with abnormal glycolipid composition from patients with Fabry's disease. Atherosclerosis 35: 155-163. doi: 10.1016/ 0021-9150(80)90081-7.
    • (1980) Atherosclerosis , vol.35 , pp. 155-163
    • Clarke, J.T.1    Stolz, J.M.2    Garner, J.B.3
  • 7
    • 23844484627 scopus 로고    scopus 로고
    • Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population
    • doi: 10.1007/s00109-005-0656-2
    • Dobrovolny R, Dvorakova L, Ledvinova J, et al (2005) Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population. J Mol Med 83: 647-654. doi: 10.1007/ s00109-005-0656-2.
    • (2005) J Mol Med , vol.83 , pp. 647-654
    • Dobrovolny, R.1    Dvorakova, L.2    Ledvinova, J.3
  • 8
    • 1642455933 scopus 로고    scopus 로고
    • Sequelae of storage in fabry disease - Pathology and comparison with other lysosomal storage diseases
    • Elleder M (2003) Sequelae of storage in fabry disease - pathology and comparison with other lysosomal storage diseases. Acta Paediatr Suppl 443: 46-53.
    • (2003) Acta Paediatr Suppl , vol.443 , pp. 46-53
    • Elleder, M.1
  • 9
    • 0025049304 scopus 로고
    • Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy
    • doi: 10.1007/BF01606034
    • Elleder M, Bradová V, Smíd F, et al (1990) Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol 417: 449-455. doi: 10.1007/ BF01606034.
    • (1990) Virchows Arch A Pathol Anat Histopathol , vol.417 , pp. 449-455
    • Elleder, M.1    Bradová, V.2    Smíd, F.3
  • 10
    • 33644524081 scopus 로고    scopus 로고
    • Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase
    • doi: 10.1136/hrt.2004.054015
    • Elliott PM, Kindler H, Shah JS, et al (2006) Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase. Heart 92: 357-360. doi: 10.1136/ hrt.2004.054015.
    • (2006) Heart , vol.92 , pp. 357-360
    • Elliott, P.M.1    Kindler, H.2    Shah, J.S.3
  • 12
    • 0036626870 scopus 로고    scopus 로고
    • Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease
    • doi: 10.1034/j.1399-0004.2002.610605.x
    • Heltianu C, Costache G, Azibi K, Poenaru L, Simionescu M (2002) Endothelial nitric oxide synthase gene polymorphisms in Fabry's disease. Clin Genet 61: 423-429. doi: 10.1034/j.1399-0004.2002.610605.x.
    • (2002) Clin Genet , vol.61 , pp. 423-429
    • Heltianu, C.1    Costache, G.2    Azibi, K.3    Poenaru, L.4    Simionescu, M.5
  • 13
    • 0033222974 scopus 로고    scopus 로고
    • [Postmortem diagnosis of fabry disease in a female heterozygote leading to the detection of undiagnosed manifest disease in the
    • Ho̊lková H, Ledvinová J, Poupětová H, Bultas J, Zeman J, Elleder M (2000) [Postmortem diagnosis of fabry disease in a female heterozygote leading to the detection of undiagnosed manifest disease in the family]. Cas Lek Cesk 138: 660-664.
    • (2000) Family] Cas Lek Cesk , vol.138 , pp. 660-664
    • Ho̊lková, H.1    Ledvinová, J.2    Poupětová, H.3    Bultas, J.4    Zeman, J.5    Elleder, M.6
  • 14
    • 19944377541 scopus 로고    scopus 로고
    • Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease
    • doi: 10.1007/s10545-005-0563-2
    • Kalliokoski RJ, Kalliokoski KK, Sundell J, et al (2005) Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease. J Inherit Metab Dis 28: 563-573. doi: 10.1007/s10545-005-0563-2.
    • (2005) J Inherit Metab Dis , vol.28 , pp. 563-573
    • Kalliokoski, R.J.1    Kalliokoski, K.K.2    Sundell, J.3
  • 15
    • 33645694070 scopus 로고    scopus 로고
    • The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease
    • doi: 10.1007/s10545-006-0221-3
    • Kalliokoski RJ, Kantola I, Kalliokoski KK, et al (2006) The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease. J Inherit Metab Dis 29: 112-118. doi: 10.1007/ s10545-006-0221-3.
    • (2006) J Inherit Metab Dis , vol.29 , pp. 112-118
    • Kalliokoski, R.J.1    Kantola, I.2    Kalliokoski, K.K.3
  • 16
    • 0034001563 scopus 로고    scopus 로고
    • Fabry disease: Ultrastructural lectin histochemical analyses of lysosomal deposits
    • doi: 10.1007/PL00008196
    • Kanda A, Nakao S, Tsuyama S, Murata F, Kanzaki T (2000) Fabry disease: ultrastructural lectin histochemical analyses of lysosomal deposits. Virchows Arch 436: 36-42. doi: 10.1007/PL00008196.
    • (2000) Virchows Arch , vol.436 , pp. 36-42
    • Kanda, A.1    Nakao, S.2    Tsuyama, S.3    Murata, F.4    Kanzaki, T.5
  • 17
    • 33746318436 scopus 로고    scopus 로고
    • Prevalence of uncontrolled hypertension in patients with fabry disease
    • doi: 10.1016/j.amjhyper.2006.01.011
    • Kleinert J, Dehout F, Schwarting A, et al (2006) Prevalence of uncontrolled hypertension in patients with fabry disease. Am J Hypertens 19: 782-787. doi: 10.1016/j.amjhyper.2006.01.011.
    • (2006) Am J Hypertens , vol.19 , pp. 782-787
    • Kleinert, J.1    Dehout, F.2    Schwarting, A.3
  • 18
    • 57649201260 scopus 로고    scopus 로고
    • TREASURE study: IntRavascular ultRasound Evaluation of Atherosclerosis regreSsion Using atoRvastatin thErapy
    • [Abstract]
    • Kovarnik T, Reznícek V, Novackova K, Horak J, Simek S, Aschermann M (2003) TREASURE study: IntRavascular ultRasound Evaluation of Atherosclerosis regreSsion Using atoRvastatin thErapy. Am J Cardiol 92 (Suppl.197L). [Abstract].
    • (2003) Am J Cardiol , vol.92 , Issue.SUPPL. 197L
    • Kovarnik, T.1    Reznícek, V.2    Novackova, K.3    Horak, J.4    Simek, S.5    Aschermann, M.6
  • 19
    • 0035149822 scopus 로고    scopus 로고
    • Cardiac manifestations in Fabry disease
    • doi: 10.1023/A:1012428009627
    • Linhart A, Lubanda J-C, Palecek T, et al (2001) Cardiac manifestations in Fabry disease. J Inherit Metab Dis 24 (Suppl 2): 75-83. doi: 10.1023/ A:1012428009627.
    • (2001) J Inherit Metab Dis , vol.24 , Issue.SUPPL. 2 , pp. 75-83
    • Linhart, A.1    Lubanda, J.-C.2    Palecek, T.3
  • 20
    • 34548316207 scopus 로고    scopus 로고
    • Cardiac manifestations of Anderson-Fabry disease: Results from the international Fabry outcome survey
    • doi: 10.1093/eurheartj/ehm153
    • Linhart A, Kampmann C, Zamorano JL, et al (2007) Cardiac manifestations of Anderson-Fabry disease: Results from the international Fabry outcome survey. Eur Heart J 28: 1228-1235. doi: 10.1093/eurheartj/ehm153.
    • (2007) Eur Heart J , vol.28 , pp. 1228-1235
    • Linhart, A.1    Kampmann, C.2    Zamorano, J.L.3
  • 21
    • 0034766525 scopus 로고    scopus 로고
    • Anderson-Fabry disease: Clinical manifestations and impact of disease in a cohort of 98 hemizygous males
    • doi: 10.1136/jmg.38.11.750
    • MacDermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38: 750-760. doi: 10.1136/jmg.38.11.750.
    • (2001) J Med Genet , vol.38 , pp. 750-760
    • MacDermot, K.D.1    Holmes, A.2    Miners, A.H.3
  • 22
    • 0035312809 scopus 로고    scopus 로고
    • American College of Cardiology Clinical Expert Consensus Document on Standards for Aquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS) A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents
    • doi: 10.1016/S0735-1097(01)01175-5
    • Mintz GS, Nissen S (2001) American College of Cardiology Clinical Expert Consensus Document on Standards for Aquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS) A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37: 1478-1492. doi: 10.1016/ S0735-1097(01)01175-5.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 1478-1492
    • Mintz, G.S.1    Nissen, S.2
  • 23
    • 0035949721 scopus 로고    scopus 로고
    • Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: Reversal by enzyme replacement therapy
    • doi: 10.1161/hc3801.096352
    • Moore DF, Scott LT, Gladwin MT, et al (2001) Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation 104: 1506-1512. doi: 10.1161/hc3801.096352.
    • (2001) Circulation , vol.104 , pp. 1506-1512
    • Moore, D.F.1    Scott, L.T.2    Gladwin, M.T.3
  • 24
    • 18244397953 scopus 로고    scopus 로고
    • Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement
    • Moore DF, Altarescu G, Ling GS, et al (2002) Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement. Stroke 33: 525-531.
    • (2002) Stroke , vol.33 , pp. 525-531
    • Moore, D.F.1    Altarescu, G.2    Ling, G.S.3
  • 25
    • 4744344117 scopus 로고    scopus 로고
    • Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality - An arterial spin tagging study
    • doi: 10.1002/jmri.20162
    • Moore DF, Ye F, Brennan ML, et al (2004) Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality - an arterial spin tagging study. J Magn Reson Imaging 20: 674-683. doi: 10.1002/jmri.20162.
    • (2004) J Magn Reson Imaging , vol.20 , pp. 674-683
    • Moore, D.F.1    Ye, F.2    Brennan, M.L.3
  • 26
    • 3042948394 scopus 로고    scopus 로고
    • Vasospastic angina in a patient with Fabry's disease who showed normal coronary angiographic findings
    • doi: 10.1253/jcj.60.315
    • Ogawa T, Kawai M, Matsui T, et al (1996) Vasospastic angina in a patient with Fabry's disease who showed normal coronary angiographic findings. Jpn Circ J 60: 315-318. doi: 10.1253/jcj.60.315.
    • (1996) Jpn Circ J , vol.60 , pp. 315-318
    • Ogawa, T.1    Kawai, M.2    Matsui, T.3
  • 27
    • 0028354071 scopus 로고
    • Correlation of intracoronary ultrasound plaque characteristics in atherosclerotic coronary artery disease patients with clinical variables
    • doi: 10.1016/0002-9149(94)90876-1
    • Rasheed Q, Nair R, Sheehan H, McB Hodgson J (1994) Correlation of intracoronary ultrasound plaque characteristics in atherosclerotic coronary artery disease patients with clinical variables. Am J Cardiol 73: 753-758. doi: 10.1016/0002-9149(94)90876-1.
    • (1994) Am J Cardiol , vol.73 , pp. 753-758
    • Rasheed, Q.1    Nair, R.2    Sheehan, H.3    Hodgson, J.McB.4
  • 28
    • 24944513802 scopus 로고    scopus 로고
    • Prevalence and clinical significance of cardiac arrhythmias in Anderson-Fabry disease
    • doi: 10.1016/j.amjcard.2005.05.033
    • Shah JS, Hughes DA, Sachdev B, et al (2005) Prevalence and clinical significance of cardiac arrhythmias in Anderson-Fabry disease. Am J Cardiol 96: 842-846. doi: 10.1016/j.amjcard.2005.05.033.
    • (2005) Am J Cardiol , vol.96 , pp. 842-846
    • Shah, J.S.1    Hughes, D.A.2    Sachdev, B.3
  • 29
    • 33644830752 scopus 로고    scopus 로고
    • Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement
    • doi: 10.1007/s00428-005-0089-x
    • Schiffmann R, Rapkiewitz A, Abu-Asab M, et al (2006) Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement. Virchows Arch 448: 337-343. doi: 10.1007/ s00428-005-0089-x.
    • (2006) Virchows Arch , vol.448 , pp. 337-343
    • Schiffmann, R.1    Rapkiewitz, A.2    Abu-Asab, M.3
  • 30
    • 0034244345 scopus 로고    scopus 로고
    • Atypical Fabry's disease presenting with cholesterol crystal embolization
    • Shirai T, Ohtake T, Kimura M, et al (2000) Atypical Fabry's disease presenting with cholesterol crystal embolization. Intern Med 39: 646-649.
    • (2000) Intern Med , vol.39 , pp. 646-649
    • Shirai, T.1    Ohtake, T.2    Kimura, M.3
  • 31
    • 0026099642 scopus 로고
    • An atypical variant of Fabry's disease with manifestation confined to the myocardium
    • von Scheidt W, Eng CM, Fitzmaurice TF, et al (1991) An atypical variant of Fabry's disease with manifestation confined to the myocardium. N Engl J Med 324: 395-399.
    • (1991) N Engl J Med , vol.324 , pp. 395-399
    • von Scheidt, W.1    Eng, C.M.2    Fitzmaurice, T.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.